Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Clin Sci (Lond) ; 138(4): 189-203, 2024 02 21.
Artigo em Inglês | MEDLINE | ID: mdl-38300615

RESUMO

Sodium bicarbonate (NaHCO3) is commonly utilized as a therapeutic to treat metabolic acidosis in people with chronic kidney disease (CKD). While increased dietary sodium chloride (NaCl) is known to promote volume retention and increase blood pressure, the effects of NaHCO3 loading on blood pressure and volume retention in CKD remain unclear. In the present study, we compared the effects of NaCl and NaHCO3 loading on volume retention, blood pressure, and kidney injury in both 2/3 and 5/6 nephrectomy remnant kidney rats, a well-established rodent model of CKD. We tested the hypothesis that NaCl loading promotes greater volume retention and increases in blood pressure than equimolar NaHCO3. Blood pressure was measured 24 h daily using radio telemetry. NaCl and NaHCO3 were administered in drinking water ad libitum or infused via indwelling catheters. Rats were housed in metabolic cages to determine volume retention. Our data indicate that both NaHCO3 and NaCl promote hypertension and volume retention in remnant kidney rats, with salt-sensitivity increasing with greater renal mass reduction. Importantly, while NaHCO3 intake was less pro-hypertensive than equimolar NaCl intake, NaHCO3 was not benign. NaHCO3 loading significantly elevated blood pressure and promoted volume retention in rats with CKD when compared with control rats receiving tap water. Our findings provide important insight into the effects of sodium loading with NaHCO3 in CKD and indicate that NaHCO3 loading in patients with CKD is unlikely to be benign.


Assuntos
Hipertensão , Insuficiência Renal Crônica , Humanos , Ratos , Animais , Bicarbonato de Sódio/farmacologia , Bicarbonato de Sódio/uso terapêutico , Cloreto de Sódio/metabolismo , Cloreto de Sódio/farmacologia , Pressão Arterial , Rim/metabolismo , Insuficiência Renal Crônica/metabolismo , Pressão Sanguínea , Cloreto de Sódio na Dieta/farmacologia
2.
J Immunol ; 200(10): 3568-3586, 2018 05 15.
Artigo em Inglês | MEDLINE | ID: mdl-29661827

RESUMO

We tested the hypothesis that oral NaHCO3 intake stimulates splenic anti-inflammatory pathways. Following oral NaHCO3 loading, macrophage polarization was shifted from predominantly M1 (inflammatory) to M2 (regulatory) phenotypes, and FOXP3+CD4+ T-lymphocytes increased in the spleen, blood, and kidneys of rats. Similar anti-inflammatory changes in macrophage polarization were observed in the blood of human subjects following NaHCO3 ingestion. Surprisingly, we found that gentle manipulation to visualize the spleen at midline during surgical laparotomy (sham splenectomy) was sufficient to abolish the response in rats and resulted in hypertrophy/hyperplasia of the capsular mesothelial cells. Thin collagenous connections lined by mesothelial cells were found to connect to the capsular mesothelium. Mesothelial cells in these connections stained positive for the pan-neuronal marker PGP9.5 and acetylcholine esterase and contained many ultrastructural elements, which visually resembled neuronal structures. Both disruption of the fragile mesothelial connections or transection of the vagal nerves resulted in the loss of capsular mesothelial acetylcholine esterase staining and reduced splenic mass. Our data indicate that oral NaHCO3 activates a splenic anti-inflammatory pathway and provides evidence that the signals that mediate this response are transmitted to the spleen via a novel neuronal-like function of mesothelial cells.


Assuntos
Acetilcolina/metabolismo , Anti-Inflamatórios/farmacologia , Colinérgicos/farmacologia , Epitélio/efeitos dos fármacos , Bicarbonato de Sódio/farmacologia , Baço/efeitos dos fármacos , Adulto , Animais , Biomarcadores/metabolismo , Epitélio/metabolismo , Feminino , Humanos , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Masculino , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Ratos , Ratos Sprague-Dawley , Baço/metabolismo , Nervo Vago/efeitos dos fármacos , Nervo Vago/metabolismo
3.
Clin Sci (Lond) ; 132(11): 1179-1197, 2018 06 15.
Artigo em Inglês | MEDLINE | ID: mdl-29650676

RESUMO

Sodium bicarbonate (NaHCO3) slows the decline in kidney function in patients with chronic kidney disease (CKD), yet the mechanisms mediating this effect remain unclear. The Dahl salt-sensitive (SS) rat develops hypertension and progressive renal injury when fed a high salt diet; however, the effect of alkali loading on kidney injury has never been investigated in this model. We hypothesized that NaHCO3 protects from the development of renal injury in Dahl salt-sensitive rats via luminal alkalization which limits the formation of tubular casts, which are a prominent pathological feature in this model. To examine this hypothesis, we determined blood pressure and renal injury responses in Dahl SS rats drinking vehicle (0.1 M NaCl) or NaHCO3 (0.1 M) solutions as well as in Dahl SS rats lacking the voltage-gated proton channel (Hv1). We found that oral NaHCO3 reduced tubular NH4+ production, tubular cast formation, and interstitial fibrosis in rats fed a high salt diet for 2 weeks. This effect was independent of changes in blood pressure, glomerular injury, or proteinuria and did not associate with changes in renal inflammatory status. We found that null mutation of Hv1 also limited cast formation in Dahl SS rats independent of proteinuria or glomerular injury. As Hv1 is localized to the luminal membrane of TAL, our data suggest that alkalization of the luminal fluid within this segment limits cast formation in this model. Reduced cast formation, secondary to luminal alkalization within TAL segments may mediate some of the protective effects of alkali loading observed in CKD patients.


Assuntos
Glomerulosclerose Segmentar e Focal/prevenção & controle , Túbulos Renais/patologia , Proteinúria/prevenção & controle , Bicarbonato de Sódio/uso terapêutico , Ácidos/urina , Animais , Glicemia/metabolismo , Modelos Animais de Doenças , Fibrose , Glomerulosclerose Segmentar e Focal/etiologia , Glomerulosclerose Segmentar e Focal/metabolismo , Hemodinâmica/efeitos dos fármacos , Concentração de Íons de Hidrogênio/efeitos dos fármacos , Canais Iônicos/deficiência , Canais Iônicos/genética , Canais Iônicos/fisiologia , Masculino , Proteinúria/metabolismo , Ratos Endogâmicos Dahl , Ratos Mutantes , Bicarbonato de Sódio/farmacologia , Cloreto de Sódio na Dieta/farmacologia , Cloreto de Sódio na Dieta/toxicidade
4.
Hypertension ; 64(3): 541-50, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24935944

RESUMO

We previously characterized a H(+) transport pathway in medullary thick ascending limb nephron segments that when activated stimulated the production of superoxide by nicotinamide adenine dinucleotide phosphate oxidase. Importantly, the activity of this pathway was greater in Dahl salt-sensitive rats than salt-resistant (SS.13(BN)) rats, and superoxide production was enhanced in low Na(+) media. The goal of this study was to determine the molecular identity of this pathway and its relationship to Na(+). We hypothesized that the voltage-gated proton channel, HV1, was the source of superoxide-stimulating H(+) currents. To test this hypothesis, we developed HV1(-/-) null mutant rats on the Dahl salt-sensitive rat genetic background using zinc-finger nuclease gene targeting. HV1 could be detected in medullary thick limb from wild-type rats. Intracellular acidification using an NH4Cl prepulse in 0 sodium/BaCl2 containing media resulted in superoxide production in thick limb from wild-type but not HV1(-/-) rats (P<0.05) and more rapid recovery of intracellular pH in wild-type rats (ΔpHI 0.005 versus 0.002 U/s, P=0.046, respectively). Superoxide production was enhanced by low intracellular sodium (<10 mmol/L) in both thick limb and peritoneal macrophages only when HV1 was present. When fed a high-salt diet, blood pressure, outer medullary renal injury (tubular casts), and oxidative stress (4-hydroxynonenal staining) were significantly reduced in HV1(-/-) rats compared with wild-type Dahl salt-sensitive rats. We conclude that HV1 is expressed in medullary thick ascending limb and promotes superoxide production in this segment when intracellular Na(+) is low. HV1 contributes to the development of hypertension and renal disease in Dahl salt-sensitive rats.


Assuntos
Hipertensão/metabolismo , Canais Iônicos/fisiologia , Nefropatias/metabolismo , Alça do Néfron/metabolismo , Sódio/metabolismo , Superóxidos/metabolismo , Animais , Modelos Animais de Doenças , Hidrogênio/metabolismo , Concentração de Íons de Hidrogênio , Hipertensão/fisiopatologia , Canais Iônicos/deficiência , Canais Iônicos/genética , Nefropatias/fisiopatologia , Alça do Néfron/citologia , Masculino , NADP/metabolismo , Técnicas de Patch-Clamp , Ratos , Ratos Endogâmicos Dahl , Ratos Mutantes , Espécies Reativas de Oxigênio/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA